Literature DB >> 17197969

Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection.

Hideki Ueno1, Hidetaka Mochizuki, Yojiro Hashiguchi, Megumi Ishiguro, Masayoshi Miyoshi, Yoshiki Kajiwara, Taichi Sato, Hideyuki Shimazaki, Kazuo Hase.   

Abstract

OBJECTIVE: To identify the parameters related to the effective selection of patients who could receive prognostic benefit from lateral pelvic node dissection.
BACKGROUND: Accurate preoperative diagnosis of lateral nodal involvement (LNI) remains difficult, and the indications for lateral lymph node dissection have been controversial. PATIENTS AND METHODS: A total of 244 consecutive patients who underwent potentially curative surgery with lateral dissection for advanced lower rectal cancer (1985-2000) were reviewed. Patients were stratified into groups based on various parameters, and the therapeutic value index for survival benefit was compared among groups. The therapeutic index of lateral dissection was calculated by multiplying the frequency of metastasis to the lateral area and the cancer-related 5-year survival rate of patients with metastasis to the lateral area, irrespective of metastasis to other areas (mesorectal, superior rectal artery [SRA], and inferior mesenteric artery [IMA] areas).
RESULTS: LNI was observed in 41 patients (17%); and 88% of them had nodal involvement in the region along the internal iliac/pudendal artery or in the obturator region ("vulnerable field"). The cancer-related 5-year survival rate among the patients with LNI was 42%; the therapeutic index for lateral dissection was calculated as 7.0 patients, which was much higher than that of lymphadenectomy of the SRA area (1.6 patients) and the IMA area (0.4 patients), and almost comparable to that of lymphadenectomy of the upward mesorectal area (6.9 patients). Although it was possible to select groups at high and low risk for LNI based on several parameters related to tumor aggressiveness, such as tumor differentiation in biopsy specimens, the therapeutic value index was not significantly different between these groups. Unlike these parameters, the diameter of the largest lymph node in the "vulnerable field," which was positively correlated with the rate of LNI but irrelevant to the prognosis, was able to successfully stratify patients by therapeutic index.
CONCLUSIONS: Advanced lower rectal cancer patients having LNI in the lateral pelvic area are likely to receive prognostic benefit from lymphadenectomy. The most efficient means of determining the effectiveness of lateral dissection preoperatively is to estimate the nodal diameter in the "vulnerable" lateral regions by diagnostic imaging.

Entities:  

Mesh:

Year:  2007        PMID: 17197969      PMCID: PMC1867942          DOI: 10.1097/01.sla.0000225359.72553.8c

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  37 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2.

Authors:  Masaaki Shimoyama; Toshiyuki Yamazaki; Takeyasu Suda; Katsuyoshi Hatakeyama
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

3.  Surgery for rectal cancer in Japan.

Authors:  J H Scholefield; W H Steup
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

4.  Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum.

Authors:  M W STEARNS; M R DEDDISH
Journal:  Dis Colon Rectum       Date:  1959 Mar-Apr       Impact factor: 4.585

5.  THE LYMPHATIC AND VENOUS SPREAD OF CARCINOMA OF THE RECTUM.

Authors:  R S Grinnell
Journal:  Ann Surg       Date:  1942-08       Impact factor: 12.969

6.  LYMPHATIC SPREAD OF CARCINOMA OF THE RECTUM.

Authors:  R K Gilchrist; V C David
Journal:  Ann Surg       Date:  1938-10       Impact factor: 12.969

7.  Local recurrence following total mesorectal excision for rectal cancer.

Authors:  G Arbman; E Nilsson; O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

8.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

9.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

10.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

View more
  46 in total

1.  Survival benefit of lateral lymph node dissection according to the region of involvement and the number of lateral lymph nodes involved.

Authors:  Shozo Yokoyama; Katsunari Takifuji; Tsukasa Hotta; Kenji Matsuda; Takashi Watanabe; Yasuyuki Mitani; Junji Ieda; Hiroki Yamaue
Journal:  Surg Today       Date:  2013-12-27       Impact factor: 2.549

2.  Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.

Authors:  S Ishihara; K Kawai; T Tanaka; T Kiyomatsu; K Hata; H Nozawa; T Morikawa; T Watanabe
Journal:  Tech Coloproctol       Date:  2018-04-06       Impact factor: 3.781

3.  Incidence and Predictive Model for Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Kapil Dev; K V Veerenderkumar; Swamyvelu Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2018-02-04

4.  Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Kenichi Sugihara
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

5.  Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.

Authors:  Atsushi Ogura; Takashi Akiyoshi; Toshiya Nagasaki; Tsuyoshi Konishi; Yoshiya Fujimoto; Satoshi Nagayama; Yosuke Fukunaga; Masashi Ueno; Hiroya Kuroyanagi
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

6.  The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2016-08-30       Impact factor: 2.571

7.  The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study.

Authors:  Liming Wang; Yasumitsu Hirano; Gregory Heng; Toshimasa Ishii; Hiroka Kondo; Kiyoka Hara; Nao Obara; Masahiro Asari; Shigeki Yamaguchi
Journal:  J Gastrointest Surg       Date:  2020-10-19       Impact factor: 3.452

8.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

9.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer.

Authors:  Shin Fujita; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.